Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.

Zou, Jifeng

Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling. [electronic resource] - Journal of biochemical and molecular toxicology Jun 2020 - e22480 p. digital

Publication Type: Journal Article

1099-0461

10.1002/jbt.22480 doi


Animals
Antineoplastic Agents, Phytogenic--pharmacology
Apoptosis--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Deoxycytidine--analogs & derivatives
Drug Resistance, Neoplasm--drug effects
Ginsenosides--pharmacology
Humans
Mice
Mice, Inbred BALB C
Mice, Nude
PTEN Phosphohydrolase--metabolism
Pancreatic Neoplasms--drug therapy
Signal Transduction--drug effects
Transfection
Tumor Burden--drug effects
Tumor Suppressor Proteins--genetics
Up-Regulation--drug effects
Xenograft Model Antitumor Assays
Gemcitabine